Thousands of low-income people living with HIV could be losing drug coverage as states impose limitations on HIV assistance programs amid constrained budgets — raising alarms over consistent access to ...
Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis ...
The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more convenient ...
(Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results